Document Detail


Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011.
MedLine Citation:
PMID:  22221972     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The 2009 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension (PH) have been adopted for Germany. While the guidelines contain detailed recommendations regarding pulmonary arterial hypertension (PAH), they contain only a relatively short paragraph on other, much more frequent forms of PH including PH owing to left heart disease. The guidelines point out that the drugs currently used to treat patients with PAH (prostanoids, endothelin receptor antagonists and phosphodiesterase type 5 inhibitors) have not been sufficiently investigated in other forms of PH. However, despite the lack of respective efficacy data an uncritical use of targeted PAH drugs in patients with PH associated with left heart disease is currently observed at an increasing rate. This development is a matter of concern. On the other hand, PH is a frequent problem that is highly relevant for morbidity and mortality in patients with left heart disease. It that sense, the practical implementation of the European Guidelines in Germany requires the consideration of several specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2010, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to PH due to left heart disease. This commentary describes in detail the results and recommendations of the working group which were last updated in October 2011.
Authors:
Stephan Rosenkranz; Diana Bonderman; Michael Buerke; Ralf Felgendreher; Henrik Ten Freyhaus; Ekkehard Grünig; Fokko de Haan; Christoph Hammerstingl; Alexander Harreuter; Wolfgang Hohenforst-Schmidt; Ingrid Kindermann; Michael Kindermann; Franz X Kleber; Matthias Kuckeland; Wolfgang M Kuebler; Dirk Mertens; Veselin Mitrovic; Christian Opitz; Alexander Schmeisser; Uwe Schulz; Rudolf Speich; Wolfgang Zeh; Joachim Weil
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  International journal of cardiology     Volume:  154S1     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2012-1-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  S34-S44     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Clinic III for Internal Medicine, Heart Center at the University of Cologne.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the ...
Next Document:  Pulmonary hypertension due to chronic lung disease: Updated Recommendations of the Cologne Consensus...